MyFinsight
Home
Blog
About
Cash and cash
equivalents
$351K
(-55.34%↓ Y/Y)
Prepaid expenses and
other current assets
$346K
(40.65%↑ Y/Y)
Prepaid research and
development
$83K
(56.60%↑ Y/Y)
Accounts receivable
$9K
(80.00%↑ Y/Y)
Total current assets
$789K
(-29.36%↓ Y/Y)
Long-term prepaid
contracts
$751K
(-2.09%↓ Y/Y)
Right-of-use assets, net
$141K
(-42.45%↓ Y/Y)
Property, plant and
equipment, net
$4K
(-50.00%↓ Y/Y)
Total assets
$1,685K
(-21.15%↓ Y/Y)
Accumulated deficit
-$109,853K
(-6.48%↓ Y/Y)
Accumulated other
comprehensive loss
-$7K
(0.00%↑ Y/Y)
Total liabilities and
stockholders (deficit)...
$1,685K
(-21.15%↓ Y/Y)
Total stockholders
(deficit) equity
-$1,379K
(-281.21%↓ Y/Y)
Additional paid-in capital
$108,305K
(4.36%↑ Y/Y)
Common stock, par value
0.01 per share,...
$176K
(10.69%↑ Y/Y)
Total liabilities
$3,064K
(122.67%↑ Y/Y)
Total current
liabilities
$3,042K
(147.12%↑ Y/Y)
Operating lease
liability, net of current...
$22K
(-84.83%↓ Y/Y)
Accrued and other
current liabilities
$1,013K
(79.93%↑ Y/Y)
Accounts payable
$757K
(115.06%↑ Y/Y)
Deferred revenue
$603K
(304.70%↑ Y/Y)
Convertible debt related
party
$500K
Operating lease liability
$123K
(18.27%↑ Y/Y)
Insurance premium
financing payable
$46K
(-26.98%↓ Y/Y)
Back
Back
Balance Sheet
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
source: myfinsight.com